Skip to content
The Policy VaultThe Policy Vault

JakafiMedical Mutual

Pediatric Acute Lymphoblastic Leukemia

Initial criteria

  • Patient is age ≥ 12 years
  • Patient has steroid-refractory disease
  • Prescribed by or in consultation with a hematologist or oncologist

Approval duration

1 year